A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Jul 2022
Historique:
received: 27 06 2022
revised: 13 07 2022
accepted: 14 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Epithelial splicing regulatory proteins 1 and 2 (ESRP1/2) control the splicing pattern during epithelial to mesenchymal transition (EMT) in a physiological context and in cancer, including breast cancer (BC). Here, we report that

Identifiants

pubmed: 35887187
pii: ijms23147835
doi: 10.3390/ijms23147835
pmc: PMC9319905
pii:
doi:

Substances chimiques

Estrogen Receptor alpha 0
RNA-Binding Proteins 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Association for Cancer Research
ID : IG15600
Organisme : Fondazione CRT
ID : 2017.0823
Organisme : University of Turin
ID : 2019 Local Research funding

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
Sci Rep. 2020 Oct 5;10(1):16504
pubmed: 33020551
Genome Res. 2016 Jun;26(6):732-44
pubmed: 27197215
Int J Mol Sci. 2020 Jan 16;21(2):
pubmed: 31963158
Mol Cancer. 2017 Jan 30;16(1):8
pubmed: 28137272
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Cancers (Basel). 2021 Dec 13;13(24):
pubmed: 34944881
Methods. 2017 Apr 15;118-119:3-15
pubmed: 27956239
Oncogene. 2016 Jul 7;35(27):3514-23
pubmed: 26522722
Bioinformatics. 2011 Apr 1;27(7):1017-8
pubmed: 21330290
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
RNA. 2018 Oct;24(10):1326-1338
pubmed: 30042172
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4892-7
pubmed: 24639548
Oncotarget. 2018 Apr 03;9(25):17876-17888
pubmed: 29707153
Oncogene. 2000 Jun 15;19(26):3013-20
pubmed: 10871853
Genome Biol. 2014;15(12):550
pubmed: 25516281
EBioMedicine. 2016 Jun;8:150-158
pubmed: 27428426
Mol Cell. 2013 Dec 12;52(5):679-92
pubmed: 24211266
Bioinformatics. 2019 Nov 1;35(21):4469-4471
pubmed: 30989184
RNA. 2014 Apr;20(4):474-82
pubmed: 24550521
Cancer Cell. 2018 Aug 13;34(2):211-224.e6
pubmed: 30078747
Lancet. 2011 Nov 19;378(9805):1812-23
pubmed: 22098854
Sci Rep. 2020 Jun 12;10(1):9544
pubmed: 32533038
Sci Rep. 2017 Aug 17;7(1):8564
pubmed: 28819152
RNA Biol. 2009 Nov-Dec;6(5):546-62
pubmed: 19829082
Elife. 2019 Sep 03;8:
pubmed: 31478829
Nucleic Acids Res. 2012 Apr;40(8):e61
pubmed: 22266656
Mol Cell Biol. 2016 May 16;36(11):1704-19
pubmed: 27044866
Mol Cell. 2009 Mar 13;33(5):591-601
pubmed: 19285943
Cells. 2019 Jan 04;8(1):
pubmed: 30621237
Nat Rev Drug Discov. 2020 Feb;19(2):112-129
pubmed: 31554928
Front Endocrinol (Lausanne). 2020 Oct 07;11:568375
pubmed: 33117284
Int J Mol Sci. 2021 May 12;22(10):
pubmed: 34065983
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Methods Mol Biol. 2013;1038:171-9
pubmed: 23872975
BMC Biol. 2021 Apr 12;19(1):70
pubmed: 33845831
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
Nat Rev Immunol. 2019 Nov;19(11):675-687
pubmed: 31363190
Clin Cancer Res. 2018 Jul 15;24(14):3397-3408
pubmed: 29661777
Genes Dev. 2010 Nov 1;24(21):2343-64
pubmed: 21041405
Clin Cancer Res. 2005 Aug 15;11(16):5678-85
pubmed: 16115903
Nature. 2013 Aug 15;500(7462):359-62
pubmed: 23873041
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nucleic Acids Res. 2014 Jan;42(Database issue):D374-9
pubmed: 24081580
PLoS Genet. 2011 Aug;7(8):e1002218
pubmed: 21876675
Wiley Interdiscip Rev RNA. 2018 Jul;9(4):e1476
pubmed: 29693319
Cell Commun Signal. 2017 May 12;15(1):19
pubmed: 28499439
Cells. 2019 Dec 04;8(12):
pubmed: 31817229
Cells. 2021 Feb 08;10(2):
pubmed: 33567745
Cell. 2020 Jan 9;180(1):208-208.e1
pubmed: 31951519
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5269-5279
pubmed: 32086391
Bioinformatics. 2012 Sep 15;28(18):2385-7
pubmed: 22820202
Oncogene. 2018 Mar;37(10):1308-1325
pubmed: 29249802
Genome Med. 2016 Aug 17;8(1):85
pubmed: 27535130
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Oncogene. 2013 Feb 14;32(7):903-9
pubmed: 22430205
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Cancers (Basel). 2020 Jun 03;12(6):
pubmed: 32503257
Nucleic Acids Res. 2017 Jul 3;45(W1):W12-W16
pubmed: 28521017
Br J Cancer. 2018 Jul;119(1):52-64
pubmed: 29899394
Int J Mol Sci. 2018 Feb 16;19(2):
pubmed: 29462945
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5593-601
pubmed: 25480548
J Mol Cell Biol. 2019 Oct 25;11(10):920-929
pubmed: 31065692
Protein Sci. 2021 Jan;30(1):187-200
pubmed: 33070389
EMBO Rep. 2019 Feb;20(2):
pubmed: 30665944
EMBO J. 2010 Oct 6;29(19):3286-300
pubmed: 20711167

Auteurs

Jamal Elhasnaoui (J)

Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Orbassano, 10043 Turin, Italy.
Candiolo Cancer Institute-FPO, IRCCS, Candiolo, 10060 Turin, Italy.

Giulio Ferrero (G)

Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Orbassano, 10043 Turin, Italy.
Department of Computer Science, School of Life Sciences, University of Turin, 10149 Turin, Italy.

Valentina Miano (V)

Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.

Lorenzo Franchitti (L)

Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Orbassano, 10043 Turin, Italy.

Isabella Tarulli (I)

Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Orbassano, 10043 Turin, Italy.

Lucia Coscujuela Tarrero (L)

Center of Genomic Science of IIT@SEMM, Italian Institute of Technologies, 20139 Milan, Italy.

Santina Cutrupi (S)

Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Orbassano, 10043 Turin, Italy.

Michele De Bortoli (M)

Department of Clinical and Biological Sciences, School of Medicine, University of Turin, Orbassano, 10043 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH